C1IC34 Stock Overview
Cigna Corporation provides insurance and related products and services in the United States.
Price History & Performance
|Historical stock prices|
|Current Share Price||US$328.69|
|52 Week High||US$352.24|
|52 Week Low||US$240.98|
|1 Month Change||8.03%|
|3 Month Change||10.11%|
|1 Year Change||-6.31%|
|3 Year Change||n/a|
|5 Year Change||n/a|
|Change since IPO||55.74%|
Recent News & Updates
|C1IC34||BR Healthcare||BR Market|
Return vs Industry: C1IC34 exceeded the BR Healthcare industry which returned -52% over the past year.
Return vs Market: C1IC34 exceeded the BR Market which returned -19.7% over the past year.
|C1IC34 Average Weekly Movement||5.7%|
|Healthcare Industry Average Movement||6.2%|
|Market Average Movement||6.3%|
|10% most volatile stocks in BR Market||9.7%|
|10% least volatile stocks in BR Market||3.2%|
Stable Share Price: C1IC34 is not significantly more volatile than the rest of BR stocks over the past 3 months, typically moving +/- 6% a week.
Volatility Over Time: C1IC34's weekly volatility (6%) has been stable over the past year.
About the Company
Cigna Corporation provides insurance and related products and services in the United States. Its Evernorth segment provides a range of coordinated and point solution health services, including pharmacy, benefits management, care delivery and management, and intelligence solutions to health plans, employers, government organizations, and health care providers. The company’s Cigna Healthcare segment offers medical, pharmacy, behavioral health, dental, vision, health advocacy programs, and other products and services for insured and self-insured customers; Medicare Advantage, Medicare Supplement, and Medicare Part D plans for seniors, as well as individual health insurance plans to on and off the public exchanges; and health care coverage in its international markets, as well as health care benefits for mobile individuals and employees of multinational organizations.
Cigna Fundamentals Summary
|C1IC34 fundamental statistics|
Is C1IC34 overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|C1IC34 income statement (TTM)|
|Cost of Revenue||US$153.96b|
Last Reported Earnings
Mar 31, 2022
Next Earnings Date
Aug 04, 2022
|Earnings per share (EPS)||16.98|
|Net Profit Margin||3.04%|
How did C1IC34 perform over the long term?See historical performance and comparison
1.7%Current Dividend Yield
Does C1IC34 pay a reliable dividends?See C1IC34 dividend history and benchmarks
|Cigna dividend dates|
|Ex Dividend Date||Jun 07 2022|
|Dividend Pay Date||Jun 29 2022|
|Days until Ex dividend||23 days|
|Days until Dividend pay date||45 days|
Does C1IC34 pay a reliable dividends?See C1IC34 dividend history and benchmarks
Is Cigna undervalued compared to its fair value and its price relative to the market?
Valuation Score 3/6
Below Fair Value
Significantly Below Fair Value
PE vs Industry
PE vs Market
PB vs Industry
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: C1IC34 (R$328.69) is trading below our estimate of fair value (R$469.53)
Significantly Below Fair Value: C1IC34 is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: C1IC34 is poor value based on its PE Ratio (15.3x) compared to the BR Healthcare industry average (12.7x).
PE vs Market: C1IC34 is poor value based on its PE Ratio (15.3x) compared to the BR market (8.7x).
Price to Earnings Growth Ratio
PEG Ratio: C1IC34 is poor value based on its PEG Ratio (2.2x)
Price to Book Ratio
PB vs Industry: C1IC34 is good value based on its PB Ratio (1.8x) compared to the BR Healthcare industry average (2.2x).
How is Cigna forecast to perform in the next 1 to 3 years based on estimates from 16 analysts?
Future Growth Score1/6
Future Growth Score 1/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: C1IC34's forecast earnings growth (6.9% per year) is below the savings rate (9.1%).
Earnings vs Market: C1IC34's earnings (6.9% per year) are forecast to grow faster than the BR market (4.5% per year).
High Growth Earnings: C1IC34's earnings are forecast to grow, but not significantly.
Revenue vs Market: C1IC34's revenue (5.2% per year) is forecast to grow slower than the BR market (6.2% per year).
High Growth Revenue: C1IC34's revenue (5.2% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: C1IC34's Return on Equity is forecast to be low in 3 years time (16.3%).
How has Cigna performed over the past 5 years?
Past Performance Score2/6
Past Performance Score 2/6
Growing Profit Margin
Earnings vs Industry
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: C1IC34 has high quality earnings.
Growing Profit Margin: C1IC34's current net profit margins (3%) are lower than last year (5.2%).
Past Earnings Growth Analysis
Earnings Trend: C1IC34's earnings have grown significantly by 27.5% per year over the past 5 years.
Accelerating Growth: C1IC34's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: C1IC34 had negative earnings growth (-36.2%) over the past year, making it difficult to compare to the Healthcare industry average (49.4%).
Return on Equity
High ROE: C1IC34's Return on Equity (11.8%) is considered low.
How is Cigna's financial position?
Financial Health Score2/6
Financial Health Score 2/6
Short Term Liabilities
Long Term Liabilities
Financial Position Analysis
Short Term Liabilities: C1IC34's short term assets ($35.4B) do not cover its short term liabilities ($43.7B).
Long Term Liabilities: C1IC34's short term assets ($35.4B) do not cover its long term liabilities ($62.8B).
Debt to Equity History and Analysis
Debt Level: C1IC34's net debt to equity ratio (60.6%) is considered high.
Reducing Debt: C1IC34's debt to equity ratio has increased from 33.2% to 71.7% over the past 5 years.
Debt Coverage: C1IC34's debt is well covered by operating cash flow (24.5%).
Interest Coverage: C1IC34's interest payments on its debt are well covered by EBIT (6.4x coverage).
What is Cigna current dividend yield, its reliability and sustainability?
Dividend Score 5/6
Future Dividend Coverage
Current Dividend Yield
Upcoming Dividend Payment
Dividend Yield vs Market
Notable Dividend: C1IC34's dividend (1.73%) is higher than the bottom 25% of dividend payers in the BR market (1.49%).
High Dividend: C1IC34's dividend (1.73%) is low compared to the top 25% of dividend payers in the BR market (6.73%).
Stability and Growth of Payments
Stable Dividend: C1IC34's dividends per share have been stable in the past 10 years.
Growing Dividend: C1IC34's dividend payments have increased over the past 10 years.
Earnings Payout to Shareholders
Earnings Coverage: With its reasonably low payout ratio (25.3%), C1IC34's dividend payments are well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its low cash payout ratio (20.5%), C1IC34's dividend payments are well covered by cash flows.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
David Cordani (56 yo)
Mr. David Michael Cordani serves as Chair of the Board at Cigna Corporation since January 01, 2022. He has been the Chief Executive Officer and President of Cigna Corporation since December 25, 2009 and Ju...
CEO Compensation Analysis
Compensation vs Market: David's total compensation ($USD19.87M) is above average for companies of similar size in the BR market ($USD6.48M).
Compensation vs Earnings: David's compensation has been consistent with company performance over the past year.
Experienced Management: C1IC34's management team is not considered experienced ( 1.5 years average tenure), which suggests a new team.
Experienced Board: C1IC34's board of directors are considered experienced (3.4 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Cigna Corporation's employee growth, exchange listings and data sources
- Name: Cigna Corporation
- Ticker: C1IC34
- Exchange: BOVESPA
- Founded: 1792
- Industry: Health Care Services
- Sector: Healthcare
- Implied Market Cap: US$82.234b
- Listing Market Cap: US$417.058b
- Shares outstanding: 317.27m
- Website: https://www.cigna.com
Number of Employees
- Cigna Corporation
- 900 Cottage Grove Road
- United States
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2022/05/14 00:00|
|End of Day Share Price||2022/05/13 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.